[Funding alert] MA-based MitoSense Secures $3.5Million in Seed Funding
Jan 22, 2024 | By Devin Jacobs
MA-based MitoSense secures $3.5million in seed funding. Lead the funding round was Caydan Capital Partners. The funding will be used by the company to further its cutting-edge research in the field of mitochondrial organelle transplantation (MOTTM).
Follow us
Follow usMitoSense is a biotechnology business that focuses on developing treatments for neurodegenerative illnesses and is committed to improving mitochondrial health through novel therapeutics and research.
Read also - WA-based Oleria Secures $33.1M in Series A Round Funding
Numerous neurodegenerative illnesses, including Huntington's, Parkinson's, multiple sclerosis, and others, may be treated with this technology.
RECOMMENDED FOR YOU
Snappt and AppFolio Partner to Strengthen Leasing Decisions Across Multifamily
Devin Jacobs
Jun 20, 2026
Funding Wrap of the Week | American Startups Funding Roundup | April 28 – May 02
Startuprise
May 3, 2025
About MitoSense
MitoSense are a research and development firm that possesses patent-pending technology that is uniquely licenced. Their technique replenishes mitochondria to combat disease, especially neurological illnesses like Parkinson's, Alzheimer's, and ALS.
Read also - Conn.-based Kusari Secures $8m in Pre-Seed & Seed Funding
Recommended Stories for You
Startuprise Dec 8, 2025
Team SR Oct 23, 2024
Team SR Jan 17, 2025
Devin Jacobs Jul 15, 2026
Devin Jacobs Apr 23, 2026
Devin Jacobs Apr 30, 2026
Trending Stories
Cyberhill Partners Raises $11M Investment
California-Based Inocras Scores $31M in Series B-3 Financing
United Therapeutics Corporation Acquires Thymmune Therapeutics
Accruent and Carter Synergy Partner to Reduce Downtime
EverLine Appoints Jason Cradit as Chief Technology Officer
[Funding News] Protect AI Raises $60 Million in Series B Funding Round
Corestream Receives Investment From Lightyear Capital
Edtech startup DeweyLearn Raises $5M in Series A Funding led by SJF Ventures
